Cargando…

Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice

Elderly patients are more susceptible to ischemic injury. N6-methyladenosine (m6A) modification is the most abundant reversible epitranscriptomic modification in mammalian RNA and plays a vital role in many biological processes. However, it is unclear whether age difference impacts m6A RNA methylati...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xuan, Shen, Yan, Jin, Yue, Kim, Il-man, Weintraub, Neal L., Tang, Yaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369344/
https://www.ncbi.nlm.nih.gov/pubmed/34413770
http://dx.doi.org/10.3389/fphar.2021.654316
_version_ 1783739274132193280
author Su, Xuan
Shen, Yan
Jin, Yue
Kim, Il-man
Weintraub, Neal L.
Tang, Yaoliang
author_facet Su, Xuan
Shen, Yan
Jin, Yue
Kim, Il-man
Weintraub, Neal L.
Tang, Yaoliang
author_sort Su, Xuan
collection PubMed
description Elderly patients are more susceptible to ischemic injury. N6-methyladenosine (m6A) modification is the most abundant reversible epitranscriptomic modification in mammalian RNA and plays a vital role in many biological processes. However, it is unclear whether age difference impacts m6A RNA methylation in hearts and their response to acute myocardial ischemia/reperfusion (I/R) injury. In this study, we measured the global level of m6A RNA methylation as well as the expression of m6A RNA “writers” (methylation enzymes) and “erasers” (demethylation enzymes) in the hearts of young and elderly female mice undergone sham surgery or acute MI/R injury. We found that m6A RNA level and associate modifier gene expression was similar in intact young and old female hearts. However, young hearts show a significant reduction in m6A RNA while elderly hearts showed only a slight reduction in m6A RNA in response to acute I/R injury. To explore the mechanism of differential level of m6A RNA modification, we use qRT-PCR and Western blotting to compare the mRNA and protein expression of major m6A-related “writers” (Mettl3, Mettl14, and WTAP) and ‘erasers” (ALKBH5 and FTO). Mettl3 mRNA and protein expression were significantly reduced in both young and elderly hearts. However, the levels of FTO’s mRNA and protein were only significantly reduced in ischemic elderly hearts, and age-related downregulation of FTO may offset the effect of reduced Mettl3 on reduced m6A RNA level in the hearts of aging mice hearts with acute I/R injury, indicating aging-related differences in epitranscriptomic m6A regulation in hearts in response to acute I/R injury. To further investigate specific I/R related targets of Mettl3, we overexpressed Mettl3 in cardiomyocyte line (HL1) using lentiviral vector, and the m6A enrichment of Bcl2, Bax and PTEN were quantified with m6A RIP-qPCR, we found that m6A modification of PTEN mRNA decreased after in vitro hypoxia/reperfusion injury (iH/R) while Mettl3 augments m6A levels of both Bax and PTEN after iH/R, indicating that Bax and PTEN are target genes of Mettl3 under iH/R stress.
format Online
Article
Text
id pubmed-8369344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83693442021-08-18 Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice Su, Xuan Shen, Yan Jin, Yue Kim, Il-man Weintraub, Neal L. Tang, Yaoliang Front Pharmacol Pharmacology Elderly patients are more susceptible to ischemic injury. N6-methyladenosine (m6A) modification is the most abundant reversible epitranscriptomic modification in mammalian RNA and plays a vital role in many biological processes. However, it is unclear whether age difference impacts m6A RNA methylation in hearts and their response to acute myocardial ischemia/reperfusion (I/R) injury. In this study, we measured the global level of m6A RNA methylation as well as the expression of m6A RNA “writers” (methylation enzymes) and “erasers” (demethylation enzymes) in the hearts of young and elderly female mice undergone sham surgery or acute MI/R injury. We found that m6A RNA level and associate modifier gene expression was similar in intact young and old female hearts. However, young hearts show a significant reduction in m6A RNA while elderly hearts showed only a slight reduction in m6A RNA in response to acute I/R injury. To explore the mechanism of differential level of m6A RNA modification, we use qRT-PCR and Western blotting to compare the mRNA and protein expression of major m6A-related “writers” (Mettl3, Mettl14, and WTAP) and ‘erasers” (ALKBH5 and FTO). Mettl3 mRNA and protein expression were significantly reduced in both young and elderly hearts. However, the levels of FTO’s mRNA and protein were only significantly reduced in ischemic elderly hearts, and age-related downregulation of FTO may offset the effect of reduced Mettl3 on reduced m6A RNA level in the hearts of aging mice hearts with acute I/R injury, indicating aging-related differences in epitranscriptomic m6A regulation in hearts in response to acute I/R injury. To further investigate specific I/R related targets of Mettl3, we overexpressed Mettl3 in cardiomyocyte line (HL1) using lentiviral vector, and the m6A enrichment of Bcl2, Bax and PTEN were quantified with m6A RIP-qPCR, we found that m6A modification of PTEN mRNA decreased after in vitro hypoxia/reperfusion injury (iH/R) while Mettl3 augments m6A levels of both Bax and PTEN after iH/R, indicating that Bax and PTEN are target genes of Mettl3 under iH/R stress. Frontiers Media S.A. 2021-08-03 /pmc/articles/PMC8369344/ /pubmed/34413770 http://dx.doi.org/10.3389/fphar.2021.654316 Text en Copyright © 2021 Su, Shen, Jin, Kim, Weintraub and Tang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Su, Xuan
Shen, Yan
Jin, Yue
Kim, Il-man
Weintraub, Neal L.
Tang, Yaoliang
Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title_full Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title_fullStr Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title_full_unstemmed Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title_short Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
title_sort aging-associated differences in epitranscriptomic m6a regulation in response to acute cardiac ischemia/reperfusion injury in female mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369344/
https://www.ncbi.nlm.nih.gov/pubmed/34413770
http://dx.doi.org/10.3389/fphar.2021.654316
work_keys_str_mv AT suxuan agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice
AT shenyan agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice
AT jinyue agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice
AT kimilman agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice
AT weintraubneall agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice
AT tangyaoliang agingassociateddifferencesinepitranscriptomicm6aregulationinresponsetoacutecardiacischemiareperfusioninjuryinfemalemice